Common Contracts
2 similar Participation Agreement contracts by Human Genome Sciences Inc, United Therapeutics Corp
PARTICIPATION AGREEMENT Dated as of June 28, 2004 among UNITED THERAPEUTICS CORPORATION, as the Construction Agent and as the Lessee, WACHOVIA DEVELOPMENT CORPORATION, as the Borrower and as the Lessor, THE VARIOUS BANKS AND OTHER LENDING INSTITUTIONS...Participation Agreement • July 6th, 2004 • United Therapeutics Corp • Pharmaceutical preparations • New York
THIS PARTICIPATION AGREEMENT, dated as of June 28, 2004 (as amended, modified, extended, supplemented, restated and/or replaced from time to time, this “Agreement”) is by and among UNITED THERAPEUTICS CORPORATION, a Delaware corporation (the “Lessee” or the “Construction Agent”); WACHOVIA DEVELOPMENT CORPORATION, a North Carolina corporation (the “Borrower” or the “Lessor”); the various banks and other financial institutions which are parties hereto from time to time as holders of the Credit Notes (subject to the definition of Credit Lenders in Appendix A hereto, individually, a “Credit Lender” and collectively, the “Credit Lenders”); the various banks and other financial institutions which are parties hereto from time to time as holders of the Mortgage Notes (subject to the definition of Mortgage Lenders in Appendix A hereto, individually, a “Mortgage Lender” and collectively, the “Mortgage Lenders”; each Credit Lender, each Mortgage Lender and the Lessor may be referred to, individua
AMENDED AND RESTATED PARTICIPATION AGREEMENT AND APPENDIX A Dated as of June 30, 2003 among HUMAN GENOME SCIENCES, INC., as the Construction Agent and as the Lessee, WACHOVIA DEVELOPMENT CORPORATION, as the Borrower and as the Lessor, VARIABLE FUNDING...Participation Agreement • August 11th, 2003 • Human Genome Sciences Inc • In vitro & in vivo diagnostic substances • New York
THIS AMENDED AND RESTATED PARTICIPATION AGREEMENT, dated as of June 30, 2003 (as amended, modified, extended, supplemented and/or restated from time to time, this “Agreement”) is by and among HUMAN GENOME SCIENCES, INC., a Delaware corporation (the “Lessee” or the “Construction Agent”); WACHOVIA DEVELOPMENT CORPORATION, a North Carolina corporation (the “Borrower” or the “Lessor”); VARIABLE FUNDING CAPITAL CORPORATION, a Delaware corporation (the “Conduit”), as a holder of a Credit Note; the Conduit, as a holder of a Mortgage Note; the various banks and other financial institutions which are parties hereto from time to time as investors (individually, an “Investor” and collectively, the “Investors”; each of the Conduit and the Investors, as a holder of a Credit Note, individually, a “Credit Lender” and collectively, the “Credit Lenders”; each of the Conduit and the Investors, as a holder of a Mortgage Note, individually, a “Mortgage Lender” and collectively, the “Mortgage Lenders”; eac
